Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...

In the latest episode of Beyond the Bottom Line, Let's Talk Healthcare Finance, Revenue Cycle and Compliance, the official podcast from Panacea Healthcare Solutions, CEO Kevin Chmura sits down once ...

Russia proposes second round of direct talks with Ukraine in Istanbul Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and ...

The field of 3D bioprinting technology is witnessing rapid advancements, offering new possibilities in regenerative medicine, ...

Bots like ChatGPT can ensnare users with philosophy that sounds profound, but we've always been susceptible to mystical ...

Discussion around international reference pricing (IRP) is intensifying as policymakers search for ways to address persistently high prescription drug costs in the United States. With news of the ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up ...

REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Biotech company Caris Life Sciences filed its paperwork to go public in the U.S. on Friday as the stock market shows signs of recovery after tariff shocks.